Cargando…
The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2410105/ http://dx.doi.org/10.1038/sj.bjc.6604419 |
| _version_ | 1782155926324641792 |
|---|---|
| author | O'Brien, P M Davies, M J Scurry, J P Smith, A N Barton, C A Henderson, M J Saunders, D N Gloss, B S Patterson, K I Clancy, J L Heinzelmann-Schwarz, V A Murali, R Scolyer, R A Zeng, Y Williams, E D Scurr, L DeFazio, A Quinn, Di Watts, C K W Hacker, N F Henshall, S M Sutherland, R L |
| author_facet | O'Brien, P M Davies, M J Scurry, J P Smith, A N Barton, C A Henderson, M J Saunders, D N Gloss, B S Patterson, K I Clancy, J L Heinzelmann-Schwarz, V A Murali, R Scolyer, R A Zeng, Y Williams, E D Scurr, L DeFazio, A Quinn, Di Watts, C K W Hacker, N F Henshall, S M Sutherland, R L |
| author_sort | O'Brien, P M |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-2410105 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2008 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-24101052009-09-10 The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro O'Brien, P M Davies, M J Scurry, J P Smith, A N Barton, C A Henderson, M J Saunders, D N Gloss, B S Patterson, K I Clancy, J L Heinzelmann-Schwarz, V A Murali, R Scolyer, R A Zeng, Y Williams, E D Scurr, L DeFazio, A Quinn, Di Watts, C K W Hacker, N F Henshall, S M Sutherland, R L Br J Cancer Corrigendum Nature Publishing Group 2008-06-03 2008-05-27 /pmc/articles/PMC2410105/ http://dx.doi.org/10.1038/sj.bjc.6604419 Text en Copyright © 2008 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Corrigendum O'Brien, P M Davies, M J Scurry, J P Smith, A N Barton, C A Henderson, M J Saunders, D N Gloss, B S Patterson, K I Clancy, J L Heinzelmann-Schwarz, V A Murali, R Scolyer, R A Zeng, Y Williams, E D Scurr, L DeFazio, A Quinn, Di Watts, C K W Hacker, N F Henshall, S M Sutherland, R L The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro |
| title | The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro |
| title_full | The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro |
| title_fullStr | The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro |
| title_full_unstemmed | The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro |
| title_short | The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro |
| title_sort | e3 ubiquitin ligase edd is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro |
| topic | Corrigendum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2410105/ http://dx.doi.org/10.1038/sj.bjc.6604419 |
| work_keys_str_mv | AT obrienpm thee3ubiquitinligaseeddisanadverseprognosticfactorforserousepithelialovariancancerandmodulatescisplatinresistanceinvitro AT daviesmj thee3ubiquitinligaseeddisanadverseprognosticfactorforserousepithelialovariancancerandmodulatescisplatinresistanceinvitro AT scurryjp thee3ubiquitinligaseeddisanadverseprognosticfactorforserousepithelialovariancancerandmodulatescisplatinresistanceinvitro AT smithan thee3ubiquitinligaseeddisanadverseprognosticfactorforserousepithelialovariancancerandmodulatescisplatinresistanceinvitro AT bartonca thee3ubiquitinligaseeddisanadverseprognosticfactorforserousepithelialovariancancerandmodulatescisplatinresistanceinvitro AT hendersonmj thee3ubiquitinligaseeddisanadverseprognosticfactorforserousepithelialovariancancerandmodulatescisplatinresistanceinvitro AT saundersdn thee3ubiquitinligaseeddisanadverseprognosticfactorforserousepithelialovariancancerandmodulatescisplatinresistanceinvitro AT glossbs thee3ubiquitinligaseeddisanadverseprognosticfactorforserousepithelialovariancancerandmodulatescisplatinresistanceinvitro AT pattersonki thee3ubiquitinligaseeddisanadverseprognosticfactorforserousepithelialovariancancerandmodulatescisplatinresistanceinvitro AT clancyjl thee3ubiquitinligaseeddisanadverseprognosticfactorforserousepithelialovariancancerandmodulatescisplatinresistanceinvitro AT heinzelmannschwarzva thee3ubiquitinligaseeddisanadverseprognosticfactorforserousepithelialovariancancerandmodulatescisplatinresistanceinvitro AT muralir thee3ubiquitinligaseeddisanadverseprognosticfactorforserousepithelialovariancancerandmodulatescisplatinresistanceinvitro AT scolyerra thee3ubiquitinligaseeddisanadverseprognosticfactorforserousepithelialovariancancerandmodulatescisplatinresistanceinvitro AT zengy thee3ubiquitinligaseeddisanadverseprognosticfactorforserousepithelialovariancancerandmodulatescisplatinresistanceinvitro AT williamsed thee3ubiquitinligaseeddisanadverseprognosticfactorforserousepithelialovariancancerandmodulatescisplatinresistanceinvitro AT scurrl thee3ubiquitinligaseeddisanadverseprognosticfactorforserousepithelialovariancancerandmodulatescisplatinresistanceinvitro AT defazioa thee3ubiquitinligaseeddisanadverseprognosticfactorforserousepithelialovariancancerandmodulatescisplatinresistanceinvitro AT quinndi thee3ubiquitinligaseeddisanadverseprognosticfactorforserousepithelialovariancancerandmodulatescisplatinresistanceinvitro AT wattsckw thee3ubiquitinligaseeddisanadverseprognosticfactorforserousepithelialovariancancerandmodulatescisplatinresistanceinvitro AT hackernf thee3ubiquitinligaseeddisanadverseprognosticfactorforserousepithelialovariancancerandmodulatescisplatinresistanceinvitro AT henshallsm thee3ubiquitinligaseeddisanadverseprognosticfactorforserousepithelialovariancancerandmodulatescisplatinresistanceinvitro AT sutherlandrl thee3ubiquitinligaseeddisanadverseprognosticfactorforserousepithelialovariancancerandmodulatescisplatinresistanceinvitro AT obrienpm e3ubiquitinligaseeddisanadverseprognosticfactorforserousepithelialovariancancerandmodulatescisplatinresistanceinvitro AT daviesmj e3ubiquitinligaseeddisanadverseprognosticfactorforserousepithelialovariancancerandmodulatescisplatinresistanceinvitro AT scurryjp e3ubiquitinligaseeddisanadverseprognosticfactorforserousepithelialovariancancerandmodulatescisplatinresistanceinvitro AT smithan e3ubiquitinligaseeddisanadverseprognosticfactorforserousepithelialovariancancerandmodulatescisplatinresistanceinvitro AT bartonca e3ubiquitinligaseeddisanadverseprognosticfactorforserousepithelialovariancancerandmodulatescisplatinresistanceinvitro AT hendersonmj e3ubiquitinligaseeddisanadverseprognosticfactorforserousepithelialovariancancerandmodulatescisplatinresistanceinvitro AT saundersdn e3ubiquitinligaseeddisanadverseprognosticfactorforserousepithelialovariancancerandmodulatescisplatinresistanceinvitro AT glossbs e3ubiquitinligaseeddisanadverseprognosticfactorforserousepithelialovariancancerandmodulatescisplatinresistanceinvitro AT pattersonki e3ubiquitinligaseeddisanadverseprognosticfactorforserousepithelialovariancancerandmodulatescisplatinresistanceinvitro AT clancyjl e3ubiquitinligaseeddisanadverseprognosticfactorforserousepithelialovariancancerandmodulatescisplatinresistanceinvitro AT heinzelmannschwarzva e3ubiquitinligaseeddisanadverseprognosticfactorforserousepithelialovariancancerandmodulatescisplatinresistanceinvitro AT muralir e3ubiquitinligaseeddisanadverseprognosticfactorforserousepithelialovariancancerandmodulatescisplatinresistanceinvitro AT scolyerra e3ubiquitinligaseeddisanadverseprognosticfactorforserousepithelialovariancancerandmodulatescisplatinresistanceinvitro AT zengy e3ubiquitinligaseeddisanadverseprognosticfactorforserousepithelialovariancancerandmodulatescisplatinresistanceinvitro AT williamsed e3ubiquitinligaseeddisanadverseprognosticfactorforserousepithelialovariancancerandmodulatescisplatinresistanceinvitro AT scurrl e3ubiquitinligaseeddisanadverseprognosticfactorforserousepithelialovariancancerandmodulatescisplatinresistanceinvitro AT defazioa e3ubiquitinligaseeddisanadverseprognosticfactorforserousepithelialovariancancerandmodulatescisplatinresistanceinvitro AT quinndi e3ubiquitinligaseeddisanadverseprognosticfactorforserousepithelialovariancancerandmodulatescisplatinresistanceinvitro AT wattsckw e3ubiquitinligaseeddisanadverseprognosticfactorforserousepithelialovariancancerandmodulatescisplatinresistanceinvitro AT hackernf e3ubiquitinligaseeddisanadverseprognosticfactorforserousepithelialovariancancerandmodulatescisplatinresistanceinvitro AT henshallsm e3ubiquitinligaseeddisanadverseprognosticfactorforserousepithelialovariancancerandmodulatescisplatinresistanceinvitro AT sutherlandrl e3ubiquitinligaseeddisanadverseprognosticfactorforserousepithelialovariancancerandmodulatescisplatinresistanceinvitro |